Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Testosterone undecanoate 250mg/mL injection solution 4mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testerone patch agent |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Accidental testosterone poisoning |
Causative agent (attribute) |
True |
Testosterone |
Inferred relationship |
Some |
2 |
Intentional testosterone poisoning (disorder) |
Causative agent (attribute) |
True |
Testosterone |
Inferred relationship |
Some |
2 |
Product containing testosterone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone decanoate (substance) |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone 17 phenylpropionate (substance) |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone isocaproate (substance) |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone undecanoate |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Dehydrotestosterone |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Implantation of testosterone implant |
Direct substance |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Epitestosterone measurement |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 30mg topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Allergy to testosterone |
Causative agent (attribute) |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Intramuscular testosterone allergy |
Causative agent (attribute) |
False |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone implant allergy |
Causative agent (attribute) |
False |
Testosterone |
Inferred relationship |
Some |
1 |
Oral testosterone allergy |
Causative agent (attribute) |
False |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing boldenone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone patch allergy |
Causative agent (attribute) |
False |
Testosterone |
Inferred relationship |
Some |
2 |
Testosterone patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone 5mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone 4mg/day |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone 15mg transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone 6mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone patch adverse reaction |
Causative agent (attribute) |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 2.5mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
|
Bound testosterone |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Bioavailable testosterone (substance) |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Product containing testosterone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone bound to sex hormone-binding globulin (SHBG) (substance) |
Is a |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone replacement therapy (procedure) |
Direct substance |
True |
Testosterone |
Inferred relationship |
Some |
2 |
Testosterone isocaproate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Testosterone propionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Dihydrotestosterone measurement (procedure) |
Component |
False |
Testosterone |
Inferred relationship |
Some |
3 |
Testosterone enantate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Bioavailable testosterone (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone cypionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Testosterone undecanoate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Testosterone decanoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Testosterone bound to sex hormone-binding globulin (SHBG) (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone 17 phenylpropionate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Testosterone |
Inferred relationship |
Some |
|
Testosterone bound to albumin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Testosterone |
Inferred relationship |
Some |
|
Testosterone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing testosterone in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 104.167 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 104.167 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 208.333 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 208.333 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing only testosterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing only testosterone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing only testosterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing only testosterone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing only testosterone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 100 mg prolonged-release subcutaneous implant |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 100 mg prolonged-release subcutaneous implant |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 200 mg prolonged-release subcutaneous implant |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 200 mg prolonged-release subcutaneous implant |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 30 mg buccal film |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 30 mg buccal film |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 10 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 10 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing testosterone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing only testosterone in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 16.2 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone 16.2 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Dihydrotestosterone measurement (procedure) |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Serum 5-alpha-dihydrotestosterone measurement |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Plasma 5-alpha-dihydrotestosterone measurement |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Plasma testosterone measurement (procedure) |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Serum testosterone measurement |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Urine free testosterone 24 hour assay |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Measurement of urine testosterone titer |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Urine free testosterone measurement |
Component |
True |
Testosterone |
Inferred relationship |
Some |
1 |
Testosterone therapy |
Direct substance |
True |
Testosterone |
Inferred relationship |
Some |
1 |